
Brain-Computer Interface System Developer


Neuralink’s valuation has grown significantly in recent years. In 2023, the company was valued at approximately $5 billion, based on private stock transaction prices. Previously, Neuralink raised $280 million in a funding round led by Peter Thiel’s Founders Fund.
Neuralink is currently testing its brain-computer interface implant, which is designed to assist patients with spinal cord injuries. The device has already enabled the first patient to control a computer directly with their brain, allowing them to play games, browse the internet, post on social media, and move the cursor on a laptop.
In 2023, the U.S. Food and Drug Administration (FDA) initially rejected Neuralink’s application to conduct clinical trials due to safety concerns. However, the agency subsequently approved its request for clinical trials, which are currently underway.
Elon Musk has grand visions for the future of Neuralink. He has stated that the company’s chips could not only assist individuals with disabilities but also enable healthy people to treat conditions such as obesity, autism, depression, and schizophrenia through rapid surgical implantation of the devices. Furthermore, he envisions these devices being used for web browsing and even achieving telepathy.
Notably, in February this year, Reuters reported that the FDA had attempted to recall some of its dismissed scientists, including those who had participated in the review of Neuralink’s devices, to reassess the relevant technologies.
Meanwhile, Neuralink’s competitor, Synchron, is also testing a similar brain-computer interface implant designed to help patients with motor impairments type on computers.
Source: IT Home
For academic sharing purposes only. If there is any infringement, please leave a message and it will be deleted immediately!
Join the Community
Welcome to the Brain-Computer Interface Community Exchange Group,
Exploring Topics in the Field of Brain-Computer Interfaces: Real-Time Tracking of Frontiers in Brain-Computer Interfaces
Add WeChat Group:
Add WeChat: RoseBCI [Note: Name + Industry/Profession].
Join QQ Group: 913607986
Call for Papers
1. Submissions are welcome. For inquiries, please contact us on WeChat: RoseBCI
Click to Submit:Submission Guidelines for Academic News in the Brain-Computer Interface Community
2. To join the community as a part-time creator, please contact us on WeChat: RoseBCI
One-Click Triple Action: “Share,” “Like,” and “Mark as Read”
Don’t Miss Any Frontier Advances in Brain-Computer Interfaces